Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01414998
Other study ID # qmul1606
Secondary ID
Status Completed
Phase N/A
First received August 10, 2011
Last updated March 19, 2013
Start date May 2012
Est. completion date March 2013

Study information

Verified date March 2013
Source Queen Mary University of London
Contact n/a
Is FDA regulated No
Health authority United Kingdom: Research Ethics Committee
Study type Interventional

Clinical Trial Summary

There are currently two sensorimotor replacement products which may be of benefit in smoking cessation: de-nicotinised cigarettes (denics) and electronic cigarettes (ECs), and the purpose of this project is to investigate whether these replacements can help to alleviate tobacco withdrawal symptoms in smokers, during a period of abstinence. This project will be separated into two studies, following the same design and procedures.

Study 1 will seek to confirm the importance of sensorimotor cues by comparing the efficacy of a nicotine-free EC in alleviating withdrawal symptoms, to a behavioural distraction tool (e.g. stress ball) which provides no smoking-related cues.

Study 2 will investigate whether sensorimotor replacements which are more proximal to smoking (i.e. Denics), will be more effective in alleviating withdrawal symptoms than a replacement which only delivers some of the conditioned sensorimotor cues (i.e. ECs).

The investigators hypothesise that the EC will be more effective at reducing withdrawal symptoms compared to the stress ball in Study 1. In Study 2, it is hypothesised that the Denic will be more effective than the EC.


Recruitment information / eligibility

Status Completed
Enrollment 120
Est. completion date March 2013
Est. primary completion date March 2013
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- 18 years or over

- Smokes at least 10 cigarettes per day

- Smokes first cigarette within 1 hour of waking

Exclusion Criteria:

- pregnant or breastfeeding

- acute psychiatric illness

- currently enrolled in other research projects

- current use of ECs or Denics

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
Stress Ball vs Nicotine-free E-Cigarette
In a cross over design, participants will be randomly allocated to: use a stress ball for 5 minutes during a 1 hour controlled experiment. They will also use the stress ball for one day outside of the study centre. use a nicotine-free EC for 5 minutes during a 1 hour controlled experiment. They will also use the EC ad-libitum for one day outside of the study centre. One week later participants will complete the other arm.
Nicotine-free E-Cigarette vs De-nicotinised Cigarette
In a cross over design, participants will be randomly allocated to: use a nicotine-free EC for 5 minutes during a 1 hour controlled experiment. They will also use the EC ad-libitum for one day outside of the study centre. smoke 1 de-nicotinised cigarette during a 1 hour controlled experiment. They will also be given a pack to smoke ad-libitum for one day outside of the study centre. One week later participants will complete the other arm.

Locations

Country Name City State
United Kingdom Tobacco Dependence Research Unit London

Sponsors (1)

Lead Sponsor Collaborator
Queen Mary University of London

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Urge to smoke at 10 minutes post product use Urges to smoke will be measured at 10 minutes after use of products 10 minutes No
Secondary Tobacco withdrawal symptom ratings over 1 hour Change withdrawal ratings one hour after product use 1 hour No
Secondary Tobacco withdrawal symptom ratings over one day Change in tobacco withdrawal symptom ratings over a day 1 day No
See also
  Status Clinical Trial Phase
Terminated NCT03840694 - Nicotine Withdrawal and Reward Processing: Connecting Neurobiology to Real-world Behavior N/A
Recruiting NCT04429568 - THC Crossover Study N/A
Terminated NCT01492322 - SPECT Imaging of DAT Genotype Phase 1
Completed NCT01954966 - Progesterone and Brain Imaging Study Phase 4
Completed NCT00749658 - Human Laboratory Study of Varenicline and Bupropion for Nicotine Dependence Phase 2/Phase 3
Completed NCT01567982 - Effects of Transcranial Direct Current Stimulation on Tobacco Withdrawal Symptoms Phase 1
Completed NCT05041959 - Nicotine Withdrawal and Reward Processing N/A
Recruiting NCT05335915 - Acute Pharmacokinetic and Pharmacodynamic Effects of "Tobacco-Free" Oral Nicotine Pouches in Smokers Phase 1
Recruiting NCT06254001 - Effectiveness of Combined Tobacco Treatment in Hospitalized Subjects Phase 4
Recruiting NCT05513872 - Overcoming Nicotine Dependence to Enable Quitting Phase 1/Phase 2
Completed NCT01204723 - Medications Development for the Treatment of Cannabis Related Disorders Phase 1
Withdrawn NCT03473483 - Cigarette Harm Reduction With Electronic Cigarette Use N/A
Active, not recruiting NCT04163081 - The INITIATE Study: Initiating Nicotine Dependence Treatment for Smokers Admitted to Emergency Departments N/A